Industry News
Pharmaceutical Industry News
Vertex Pharmaceuticals has gained…
Vertex Pharmaceuticals has gained a label expansion from the FDA, which allows children ages 2 and up to receive the gene therapy Casgevy for the treatment of sickle cell disease or transfusion-dependent beta thalassemia. The
Amgen has issued a voluntary…
Amgen has issued a voluntary recall for nearly 1 million bottles of the heart medication Corlanor (ivabradine) due to possible contamination.
The ad uses hand-crafted puppets…
The ad uses hand-crafted puppets to portray sight-based frustrations for those with presbyopia, a common condition that causes blurry up-close vision.
Contract manufacturing powerhouse…
Contract manufacturing powerhouse Lonza is growing in more ways than one. The Swiss company revealed this week that it is expanding its capacity to manufacture antibody-drug conjugates—and that it has increased the scope of its
After a site visit by FDA…
After a site visit by FDA inspectors yielded a Form 483 for Genzyme Ireland in early 2026, the Sanofi subsidiary is facing further reprimand from the U.S. regulator.
As BridgeBio ramps up for the…
As BridgeBio ramps up for the launch of three new medicines and continues to channel resources into its soon-to-be-blockbuster in ATTR-CM, Attruby, Sixth Street and HealthCare Royalty have agreed to invest up to $1 billion
On a quest to bolster its life-sci…
On a quest to bolster its life-sci contracting bona fides, self-described “multifaceted manufacturer” Kimball Electronics is going down the path of M&A.
Consumer health giant Haleon has…
Consumer health giant Haleon has tapped Microsoft to incorporate AI across its operations, joining a growing wave of healthcare and life sciences heavyweights turning to Big Tech to execute enterprise-wide digital overhauls.
What Older Adults Should Know About GLP-1 Drugs as Medicare Coverage Expands
A Medicare pilot beginning Wednesday will broaden access to medications like Wegovy and Zepbound. There are unique risks for those over 65.
Plus Therapeutics is evolving its…
Plus Therapeutics is evolving its business and has rebranded as Cerenome to reflect its expansion.
Orca Bio has jumped into the…
Orca Bio has jumped into the commercial market with an FDA approval for Tregzi, a first-of-its-kind allogeneic regulatory T cell-based therapy for blood cancer patients requiring transplants.
AstraZeneca will pay $34 million…
AstraZeneca will pay $34 million to resolve a lawsuit that alleged the company used illegal kickbacks to induce providers to write prescriptions for products paid for by Texas Medicaid.
With more than a decade since the…
With more than a decade since the first FDA biosim approval, strong launches of biologic copies of AbbVie’s Humira, J&J’s Stelara and Regeneron/Bayer’s Eylea are shifting a narrative once focused on lagging uptake of the
As Amgen’s rare disease…
As Amgen’s rare disease medicine Tavneos comes under intensifying pressure from the FDA, the company faces a new hurdle with a leading medical journal’s retraction of the drug’s pivotal study data.
Despite a recent failure as a…
Despite a recent failure as a second-line monotherapy in diffuse B-cell lymphoma, a positive phase 3 combination trial for AbbVie and Genmab’s Epkinly has renewed confidence ahead of its high-stakes first-line readout.
Eli Lilly, Regeneron and Fujifilm…
Eli Lilly, Regeneron and Fujifilm are among the seven companies that have been selected to participate in the FDA's PreCheck Pilot Program, designed to strengthen drug manufacturing and supply chain resilience in the U.S. The
Unicycive is optimistic the…
Unicycive is optimistic the third-party manufacturing facility can meet FDA standards to support an approval, CEO Shalabh Gupta, M.D., said in a statement.
AstraZeneca has impressed oncology…
AstraZeneca has impressed oncology patient groups, rising to second place on PatientView’s corporate reputation ranking on the back of strength in breast and lung cancer. Roche, a familiar sight at the top of PatientView’s cancer
Tara Sparks was just days away…
Tara Sparks was just days away from starting her new job at Novo Nordisk in February 2025 when she gathered with some friends to watch her team, the Philadelphia Eagles, take on reigning Super Bowl
CMI Media Group’s Ad Astra…
CMI Media Group's Ad Astra platform looks to connect siloed pharma marketing technologies, with its initial focus targeting omnichannel orchestration.